| Bioactivity | Cibenzoline succinate (Cifenline succinate) is the succinate form of Cibenzoline (HY-106577). Cibenzoline succinate is an inhibitor for ATP-sensitive potassium (KATP) channel by affecting the pore-forming Kir6.2 subunit with IC50 of 22.2 µM. Cibenzoline succinate affects insulin secretion and exhibits antiarrhythmic and antidiabetic activities[1]. |
| CAS | 100678-32-8 |
| Formula | C22H24N2O4 |
| Molar Mass | 380.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Mukai E, et al., The antiarrhythmic agent cibenzoline inhibits KATP channels by binding to Kir6.2. Biochem Biophys Res Commun. 1998 Oct 20;251(2):477-81. |
Cibenzoline succinate
CAS: 100678-32-8 F: C22H24N2O4 W: 380.44
Cibenzoline succinate (Cifenline succinate) is the succinate form of Cibenzoline (HY-106577). Cibenzoline succinate is a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.